209 related articles for article (PubMed ID: 22350310)
1. MiR-181b: new perspective to evaluate disease progression in chronic lymphocytic leukemia.
Visone R; Veronese A; Balatti V; Croce CM
Oncotarget; 2012 Feb; 3(2):195-202. PubMed ID: 22350310
[TBL] [Abstract][Full Text] [Related]
2. miR-181b is a biomarker of disease progression in chronic lymphocytic leukemia.
Visone R; Veronese A; Rassenti LZ; Balatti V; Pearl DK; Acunzo M; Volinia S; Taccioli C; Kipps TJ; Croce CM
Blood; 2011 Sep; 118(11):3072-9. PubMed ID: 21636858
[TBL] [Abstract][Full Text] [Related]
3. CARD11 is a novel target of miR-181b that is upregulated in chronic lymphocytic leukemia.
Kou Z; Mao M; Liu H; Wang X; Wang Z; Gu Z; Lang T; Nie Y; Wang Y; Huang Q; An L; Zhang X; Fu L; Li Y
Biomark Med; 2021 Jun; 15(9):623-635. PubMed ID: 34039026
[No Abstract] [Full Text] [Related]
4. miR-34a and miR-29b as indicators for prognosis of treatment-free survival of chronic lymphocytic leukemia patients in Chinese Uygur and Han populations.
Li Y; Mao M; Liu H; Wang X; Kou Z; Nie Y; Wang Y; Wang Z; Huang Q; Lang T; Gu Z; An L; Zhang X; Fu L
Mol Cell Probes; 2019 Oct; 47():101436. PubMed ID: 31425738
[TBL] [Abstract][Full Text] [Related]
5. Aberrant expression profile of miR-32, miR-98 and miR-374 in chronic lymphocytic leukemia.
Rahimi Z; Ghorbani Z; Motamed H; Jalilian N
Leuk Res; 2021 Dec; 111():106691. PubMed ID: 34455196
[TBL] [Abstract][Full Text] [Related]
6. State of the art in microRNA as diagnostic and therapeutic biomarkers in chronic lymphocytic leukemia.
Mirzaei H; Fathullahzadeh S; Khanmohammadi R; Darijani M; Momeni F; Masoudifar A; Goodarzi M; Mardanshah O; Stenvang J; Jaafari MR; Mirzaei HR
J Cell Physiol; 2018 Feb; 233(2):888-900. PubMed ID: 28084621
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-223 expression is uniformly down-regulated in B cell lymphoproliferative disorders and is associated with poor survival in patients with chronic lymphocytic leukemia.
Zhou K; Yi S; Yu Z; Li Z; Wang Y; Zou D; Qi J; Zhao Y; Qiu L
Leuk Lymphoma; 2012 Jun; 53(6):1155-61. PubMed ID: 22145958
[TBL] [Abstract][Full Text] [Related]
8. CD markers variations in chronic lymphocytic leukemia: New insights into prognosis.
Vosoughi T; Bagheri M; Hosseinzadeh M; Ehsanpour A; Davari N; Saki N
J Cell Physiol; 2019 Nov; 234(11):19420-19439. PubMed ID: 31049958
[TBL] [Abstract][Full Text] [Related]
9. Is miR-29 an oncogene or tumor suppressor in CLL?
Pekarsky Y; Croce CM
Oncotarget; 2010 Jul; 1(3):224-7. PubMed ID: 20936047
[TBL] [Abstract][Full Text] [Related]
10. MicroRNAs in chronic lymphocytic leukemia: miRacle or miRage for prognosis and targeted therapies?
Van Roosbroeck K; Calin GA
Semin Oncol; 2016 Apr; 43(2):209-14. PubMed ID: 27040698
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic Value of Plasma miR-145 and miR-185 as Targeting of the APRIL Oncogene in the B-cell Chronic Lymphocytic Leukemia.
Bagheri M; Khansarinejad B; Mosayebi G; Moradabadi A; Mondanizadeh M
Asian Pac J Cancer Prev; 2021 Jan; 22(1):111-117. PubMed ID: 33507687
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA expression profiling identifies activated B cell status in chronic lymphocytic leukemia cells.
Li S; Moffett HF; Lu J; Werner L; Zhang H; Ritz J; Neuberg D; Wucherpfennig KW; Brown JR; Novina CD
PLoS One; 2011 Mar; 6(3):e16956. PubMed ID: 21408091
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of miR-155 in individuals with monoclonal B-cell lymphocytosis and patients with B chronic lymphocytic leukemia.
Ferrajoli A; Shanafelt TD; Ivan C; Shimizu M; Rabe KG; Nouraee N; Ikuo M; Ghosh AK; Lerner S; Rassenti LZ; Xiao L; Hu J; Reuben JM; Calin S; You MJ; Manning JT; Wierda WG; Estrov Z; O'Brien S; Kipps TJ; Keating MJ; Kay NE; Calin GA
Blood; 2013 Sep; 122(11):1891-9. PubMed ID: 23821659
[TBL] [Abstract][Full Text] [Related]
14. Inactivation of TP53 correlates with disease progression and low miR-34a expression in previously treated chronic lymphocytic leukemia patients.
Dufour A; Palermo G; Zellmeier E; Mellert G; Duchateau-Nguyen G; Schneider S; Benthaus T; Kakadia PM; Spiekermann K; Hiddemann W; Braess J; Truong S; Patten N; Wu L; Lohmann S; Dornan D; GuhaThakurta D; Yeh RF; Salogub G; Solal-Celigny P; Dmoszynska A; Robak T; Montillo M; Catalano J; Geisler CH; Weisser M; Bohlander SK
Blood; 2013 May; 121(18):3650-7. PubMed ID: 23525797
[TBL] [Abstract][Full Text] [Related]
15. microRNA and Chronic Lymphocytic Leukemia.
Giza DE; Calin GA
Adv Exp Med Biol; 2015; 889():23-40. PubMed ID: 26658994
[TBL] [Abstract][Full Text] [Related]
16. Chronic lymphocytic leukemia modeled in mouse by targeted miR-29 expression.
Santanam U; Zanesi N; Efanov A; Costinean S; Palamarchuk A; Hagan JP; Volinia S; Alder H; Rassenti L; Kipps T; Croce CM; Pekarsky Y
Proc Natl Acad Sci U S A; 2010 Jul; 107(27):12210-5. PubMed ID: 20566844
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of MiR-15a and MiR-16-1 as prognostic biomarkers in chronic lymphocytic leukemia.
Braga TV; Evangelista FCG; Gomes LC; Araújo SSDS; Carvalho MDG; Sabino AP
Biomed Pharmacother; 2017 Aug; 92():864-869. PubMed ID: 28599250
[TBL] [Abstract][Full Text] [Related]
18. Evolving DNA methylation and gene expression markers of B-cell chronic lymphocytic leukemia are present in pre-diagnostic blood samples more than 10 years prior to diagnosis.
Georgiadis P; Liampa I; Hebels DG; Krauskopf J; Chatziioannou A; Valavanis I; de Kok TMCM; Kleinjans JCS; Bergdahl IA; Melin B; Spaeth F; Palli D; Vermeulen RCH; Vlaanderen J; Chadeau-Hyam M; Vineis P; Kyrtopoulos SA;
BMC Genomics; 2017 Sep; 18(1):728. PubMed ID: 28903739
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors in chronic lymphocytic leukemia-what do we need to know?
Cramer P; Hallek M
Nat Rev Clin Oncol; 2011 Jan; 8(1):38-47. PubMed ID: 20956983
[TBL] [Abstract][Full Text] [Related]
20. Elevated miR-20b-5p expression in peripheral blood mononuclear cells: A novel, independent molecular biomarker of favorable prognosis in chronic lymphocytic leukemia.
Papageorgiou SG; Kontos CK; Tsiakanikas P; Stavroulaki G; Bouchla A; Vasilatou D; Bazani E; Lazarakou A; Scorilas A; Pappa V
Leuk Res; 2018 Jul; 70():1-7. PubMed ID: 29715621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]